Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,396 | 662 | 95.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $400.00 | 1 | 3.1% |
| Education | $144.61 | 2 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,484 | 201 | $0 (2024) |
| QOL Medical, LLC | $1,323 | 55 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $890.96 | 54 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $800.47 | 41 | $0 (2024) |
| Celgene Corporation | $784.59 | 62 | $0 (2024) |
| Janssen Biotech, Inc. | $683.87 | 33 | $0 (2024) |
| Gilead Sciences, Inc. | $605.29 | 34 | $0 (2024) |
| INTERCEPT PHARMACEUTICALS, INC. | $434.98 | 13 | $0 (2023) |
| Ardelyx, Inc. | $332.20 | 16 | $0 (2024) |
| SHIELD THERAPEUTICS INC | $296.99 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,319 | 109 | ABBVIE INC. ($450.36) |
| 2023 | $2,439 | 127 | AbbVie Inc. ($613.44) |
| 2022 | $1,933 | 107 | ABBVIE INC. ($528.52) |
| 2021 | $1,801 | 110 | AbbVie Inc. ($508.79) |
| 2020 | $1,776 | 65 | QOL Medical, LLC ($491.87) |
| 2019 | $1,024 | 59 | QOL Medical, LLC ($395.51) |
| 2018 | $979.80 | 51 | AbbVie, Inc. ($519.35) |
| 2017 | $667.85 | 37 | AbbVie, Inc. ($292.73) |
All Payment Transactions
665 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Hematology | ||||||
| 12/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.39 | General |
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.63 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: Gastroenterology | ||||||
| 11/22/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Gastroenterology | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.20 | General |
| 11/19/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Boston Scientific Corporation | Resolution 360 Clip (Device) | Food and Beverage | In-kind items and services | $54.12 | General |
| Category: Resolution 360 Clip_ENDO | ||||||
| 11/13/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $3.41 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/11/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Hematology | ||||||
| 11/07/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Hematology | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $25.40 | General |
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $29.74 | General |
| Category: VIROLOGY | ||||||
| 10/30/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: GI | ||||||
| 10/24/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Hematology | ||||||
| 10/17/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 792 | 961 | $405,637 | $96,647 |
| 2022 | 16 | 902 | 1,219 | $435,579 | $108,765 |
| 2021 | 13 | 786 | 1,046 | $375,755 | $95,126 |
| 2020 | 12 | 738 | 977 | $335,538 | $80,048 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 181 | 266 | $72,841 | $24,788 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 135 | 135 | $40,500 | $14,910 | 36.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 49 | 49 | $46,550 | $9,691 | 20.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 70 | 70 | $59,500 | $7,846 | 13.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 102 | 106 | $71,550 | $7,603 | 10.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 117 | $21,295 | $7,574 | 35.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 35 | 36 | $18,941 | $4,763 | 25.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 62 | $11,990 | $3,888 | 32.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $8,500 | $3,556 | 41.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 20 | 20 | $15,000 | $3,533 | 23.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 17 | $12,750 | $3,015 | 23.6% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $13,875 | $2,708 | 19.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 12 | $9,000 | $1,753 | 19.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 12 | 36 | $3,345 | $1,020 | 30.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 215 | 321 | $87,903 | $30,836 | 35.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 168 | 168 | $50,400 | $18,295 | 36.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 111 | 115 | $77,625 | $7,832 | 10.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 39 | 40 | $38,000 | $7,458 | 19.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 67 | 75 | $13,651 | $4,902 | 35.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 55 | 55 | $46,750 | $4,813 | 10.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 26 | 66 | $14,870 | $4,743 | 31.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 26 | 26 | $11,050 | $4,601 | 41.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 28 | $14,732 | $4,481 | 30.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 27 | 70 | $13,018 | $4,006 | 30.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 48 | 135 | $12,543 | $3,813 | 30.4% |
About Dr. J Sun, MD
Dr. J Sun, MD is a Gastroenterology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124175005.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. J Sun, MD has received a total of $12,940 in payments from pharmaceutical and medical device companies, with $2,319 received in 2024. These payments were reported across 665 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($12,396).
As a Medicare-enrolled provider, Sun has provided services to 3,218 Medicare beneficiaries, totaling 4,203 services with total Medicare billing of $380,585. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Houston, TX
- Active Since 01/04/2007
- Last Updated 02/16/2023
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1124175005
Products in Payments
- Sucraid (Drug) $1,120
- ZEPOSIA (Drug) $878.43
- LINZESS (Drug) $722.71
- MAVYRET (Drug) $697.90
- XIFAXAN (Drug) $528.66
- REMICADE (Biological) $523.37
- OCALIVA (Drug) $434.98
- Humira (Biological) $357.66
- RINVOQ (Biological) $357.10
- DUPIXENT (Biological) $345.97
- IBSRELA (Drug) $332.20
- SKYRIZI (Biological) $307.92
- ACCRUFER (Drug) $296.99
- ENTYVIO (Biological) $288.71
- TRULANCE (Drug) $281.87
- HUMIRA (Biological) $265.40
- VOQUEZNA (Drug) $250.00
- Creon (Drug) $246.15
- ZENPEP (Drug) $216.31
- MOTEGRITY (Drug) $207.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Houston
Dr. Bincy Abraham, Md, MD
Gastroenterology — Payments: $1.9M
Dr. Isaac Raijman, Md, MD
Gastroenterology — Payments: $1.6M
Dr. Brooks Cash, Md, MD
Gastroenterology — Payments: $1.3M
Dr. Mazen Noureddin, M.d, M.D
Gastroenterology — Payments: $786,099
Dr. Jason Hou, M.d, M.D
Gastroenterology — Payments: $372,514
Kalpesh Patel, Md, MD
Gastroenterology — Payments: $313,187